End-stage renal disease (ESRD) is a rare but debilitating disease, occurring in 5-10 children per million children every year. 1,2 Children with ESRD face thirty times the mortality compared with healthy children; however, in the last fifty years, kidney transplants have proven to be an effective treatment. 2 Recent increased successes can be attributed to improvements in immunosuppressive therapy, surgical technique, improved infection prophylaxis, and more